by Jordana Choucair | Dec 2, 2021 | Life Sciences
GlaxoSmithKline PLC and Vir Biotechnology Inc. said their COVID-19 antibody treatment was effective against the omicron variant in early lab tests. The drugmaker said that lab tests of the mutations found in the variant showed the drug is still active against the...
by Jordana Choucair | Dec 2, 2021 | Health IT
A survey conducted by Rand Corporation found that the 53 percent of U.S. patients prefer a traditional in-office visit over a video visit for nonemergent care. Sixty-seven percent of participants preferred at least some video visits in the future. Participants...
by Jordana Choucair | Dec 2, 2021 | D.C. News
House Appropriations Committee Chairwoman Rosa DeLauro announced Thursday morning that House Democrats have agreed to move forward with a continuing resolution that would keep the government funded through February 18. However, Republicans in the House and the Senate...
by Jordana Choucair | Dec 2, 2021 | D.C. News
The White House announced that President Biden today will outline a plan to combat COVID-19 this winter. The plan is expected to include allowing private health insurance to cover rapid, at-home test kits, extending mask mandates on public transportation through March...
by Jordana Choucair | Dec 2, 2021 | Access & Coverage
The Supreme Court’s conservative majority signaled that it will uphold a Mississippi law banning abortion after 15 weeks of pregnancy. The state’s 2018 law contains abortion restrictions contrary to precedent set in the landmark 1973 Roe v. Wade decision. Chief...
by Jordana Choucair | Dec 2, 2021 | Transition to Value
The Center for Medicare and Medicaid Innovation withdrew a program focused on care coordination for seriously ill Medicare patients without primary care doctors. The program, which was intended to be part of the Primary Care First model, was nixed after a review found...
Recent Comments